Brook H Byers - Net Worth and Insider Trading

Brook H Byers Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brook H Byers owns 4 companies in total, including CareDx Inc (CDNA) , Pacific Biosciences of California Inc (PACB) , and Foundation Medicine Inc (FMI) among others .

Click here to see the complete history of Brook H Byers’s form 4 insider trades.

Insider Ownership Summary of Brook H Byers

Ticker	Company	Transaction Date	Type of Owner
CDNA	CareDx Inc	2015-07-01	director & 10 percent owner
PACB	Pacific Biosciences of California Inc	2010-10-26	director
FMI	Foundation Medicine Inc	2015-04-07	director
		2013-10-29	director & 10 percent owner

Brook H Byers Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Brook H Byers Ownership Network

Ownership Network List of Brook H Byers

No Data

Ownership Network Relation of Brook H Byers

Brook H Byers Owned Company Details

What does CareDx Inc do?

Who are the key executives at CareDx Inc?

Brook H Byers is the director & 10 percent owner of CareDx Inc. Other key executives at CareDx Inc include See Remarks Abhishek Jain , director & President and CEO Peter Maag , and Chief Business Officer Alexander L Johnson .

CareDx Inc (CDNA) Insider Trades Summary

Over the past 18 months, Brook H Byers made no insider transaction in CareDx Inc (CDNA). Other recent insider transactions involving CareDx Inc (CDNA) include a net sale of 13,110 shares made by , a net sale of 95,254 shares made by Alexander L Johnson , and a net sale of 40,552 shares made by Peter Maag .

In summary, during the past 3 months, insiders sold 24,701 shares of CareDx Inc (CDNA) in total and bought 0 shares, with a net sale of 24,701 shares. During the past 18 months, 169,181 shares of CareDx Inc (CDNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 169,181 shares.

CareDx Inc (CDNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

CareDx Inc Insider Transactions

No Available Data

What does Pacific Biosciences of California Inc do?

Who are the key executives at Pacific Biosciences of California Inc?

Brook H Byers is the director of Pacific Biosciences of California Inc. Other key executives at Pacific Biosciences of California Inc include Chief Operating Officer Oene Mark Van , Chief Accounting Officer Michele Farmer , and See Remarks Jeff Eidel .

Pacific Biosciences of California Inc (PACB) Insider Trades Summary

Over the past 18 months, Brook H Byers made no insider transaction in Pacific Biosciences of California Inc (PACB). Other recent insider transactions involving Pacific Biosciences of California Inc (PACB) include a net sale of 253,433 shares made by Oene Mark Van , a net sale of 486,507 shares made by Christian O Henry , and a net sale of 43,127 shares made by Michele Farmer .

In summary, during the past 3 months, insiders sold 406,987 shares of Pacific Biosciences of California Inc (PACB) in total and bought 0 shares, with a net sale of 406,987 shares. During the past 18 months, 853,927 shares of Pacific Biosciences of California Inc (PACB) were sold and 40,000 shares were bought by its insiders, resulting in a net sale of 813,927 shares.

Pacific Biosciences of California Inc (PACB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pacific Biosciences of California Inc Insider Transactions

No Available Data

What does Foundation Medicine Inc do?

Who are the key executives at Foundation Medicine Inc?

Brook H Byers is the director of Foundation Medicine Inc. Other key executives at Foundation Medicine Inc include Chief Commercial Officer Thomas Civik , Chief Medical Officer Vincent A. Miller , and Chief Financial Officer Jason Ryan .

Foundation Medicine Inc (FMI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Foundation Medicine Inc (FMI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Foundation Medicine Inc (FMI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Foundation Medicine Inc (FMI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Foundation Medicine Inc Insider Transactions

No Available Data

What does Veracyte Inc do?

Who are the key executives at Veracyte Inc?

Brook H Byers is the director & 10 percent owner of Veracyte Inc. Other key executives at Veracyte Inc include Chief Commercial Officer-CLIA John Leite , Chief Scientific & Med Officer Phillip G. Febbo , and SVP & General Counsel Annie Mcguire .

Veracyte Inc (VCYT) Insider Trades Summary

Over the past 18 months, Brook H Byers made no insider transaction in Veracyte Inc (VCYT). Other recent insider transactions involving Veracyte Inc (VCYT) include a net sale of 75,012 shares made by Evan/ Fa Jones , a net sale of 38,601 shares made by Karin Eastham , and a net sale of 20,963 shares made by John Leite .

In summary, during the past 3 months, insiders sold 75,560 shares of Veracyte Inc (VCYT) in total and bought 0 shares, with a net sale of 75,560 shares. During the past 18 months, 283,874 shares of Veracyte Inc (VCYT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 283,874 shares.

Veracyte Inc (VCYT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Veracyte Inc Insider Transactions

No Available Data

Brook H Byers Mailing Address

Above is the net worth, insider trading, and ownership report for Brook H Byers. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Brook H Byers's mailing address is: Menlo Park Ca 94025.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.